Results 251 to 260 of about 724,197 (388)

Postoperative Thrombocytopenia in Cardiac Surgery: Patterns, Differential Diagnosis and Management of Heparin-Induced Thrombocytopenia (HIT). [PDF]

J Clin Med
Ampatzidou F, Argyriadou E, Amaniti C, Sarridou D.   +3 more
europepmc   +1 more source

Increased Heparin Binding in Cystic Fibrosis: A Reflection of Altered Glycoprotein Biosynthesis? [PDF]

, 1979
Ronald D Pearson, A Harold Lubin
openalex   +1 more source

Bivalirudin vs heparin with or without tirofiban during primary percutaneous coronary intervention in acute myocardial infarction: the BRIGHT randomized clinical trial.

Journal of the American Medical Association (JAMA), 2015
Yaling Han, Jincheng Guo, Yang Zheng, Hong-yun Zang, X. Su, Yu Wang, Shaoliang Chen, Tieming Jiang, Ping Yang, Ji-yan Chen, D. Jiang, Quanmin Jing, Zhenyang Liang, Haiwei Liu, Xin Zhao, Jing Li, Yi Li, Bo Xu, G. Stone   +18 more
semanticscholar   +1 more source

Synthetic heparin

Current Opinion in Pharmacology, 2012
Linhardt, Robert J, Liu, Jian
openaire   +2 more sources

A real‐world data‐driven approach to optimizing enoxaparin dosing in burn patients

British Journal of Clinical Pharmacology, EarlyView.
Aim Enoxaparin dosing in burn patients is challenging due to physiological changes affecting absorption, distribution and clearance. The objectives of this study are to develop a population pharmacokinetic (PK) model for enoxaparin in burn patients, evaluate target attainment with current equation‐based (EQ) dosing and propose an optimized dosing ...
Babajide Shenkoya, Venkata Yellepeddi, Ann Marie B. Prazak, Mathangi Gopalakrishnan   +3 more
wiley   +1 more source

Pooled Incidence of Heparin-Induced Thrombocytopenia and Anti-Platelet Factor 4 Antibody Formation Among Adults: A Systematic Review and Meta-Analysis. [PDF]

Cureus
Devarapalli A, Rachamanti R, Singampalli M, Hullur K.   +3 more
europepmc   +1 more source

Comparative effectiveness and safety of Argatroban and Bivalirudin in Patients with suspected Heparin-induced Thrombocytopenia [PDF]

, 2015
Vardhaman Patel, William Galanter, T.A. Lee, Glen T. Schumock, Edith A. Nutescu, Sam Hohmann, S.M. Walton   +6 more
openalex   +1 more source

Clot-bound thrombin is protected from inhibition by heparin-antithrombin III but is susceptible to inactivation by antithrombin III-independent inhibitors.

Journal of Clinical Investigation, 1990
J. Weitz, M. Hudoba, D. Massel, J. Maraganore, J. Hirsh   +4 more
semanticscholar   +1 more source

Effect of enzalutamide on anticoagulant therapy with edoxaban in patients with prostate cancer

British Journal of Clinical Pharmacology, EarlyView.
Aims Treatment with enzalutamide in prostate cancer is challenging due to its high potential for drug–drug interactions, particularly in the typically older population of patients with frequent comorbidities treated with multiple drugs, such as anticoagulants.
Catharina J. P. Op 't Hoog, Niven Mehra, Anouk van Kleef, Diederik M. Somford, Inge M. van Oort, Alex L. T. Imholz, Paul Hamberg, Nielka P. van Erp, Emmy Boerrigter   +8 more
wiley   +1 more source

N-Sulfated Heparan Sulfate Promotes Reelin Signaling as a Co-receptor. [PDF]

J Am Chem Soc
Pan L, Song X, Su G, Gandy LA, Fang B, Buttaci M, Gibson J, Xia K, Zhang F, Liu J, Wang L, Temple S, Wang C.   +12 more
europepmc   +1 more source